The global human liver models market size is expected to reach USD 5.5 Billion by 2028 and register a CAGR of 13.9% over the forecast period, according to the latest report by Reports and Data.
The global human liver models market size is expected to reach USD 5.5 Billion by 2028 and register a CAGR of 13.9% over the forecast period, according to the latest report by Reports and Data. Increasing emphasis on developing enhanced liver models as an alternative to animal testing models is boosting global human live models market revenue growth currently.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/4015
The liver plays a vital role in a variety of functions such as production of bile, blood clotting synthesis, and synthesis of glucose. Liver models are obtained from single fetal progenitor live cells. These models offer a virtual ecosystem that mimics molecular process, physiology, and anatomy of the liver. These liver models are known as organoids and are gaining increasing preference over animal testing models. High adoption of human liver models for novel drug screening, increasing investments in research and development activities by leading companies, and government initiatives to promote liver organoids are factors fueling market growth. Rising prevalence liver infections and utilization of liver models for developing various drugs and gene therapy is further augmenting growth of the global market.
Major market players are deploying various strategies such as entering into mergers and acquisitions, collaborations, and joint ventures, and launching new product to sustain drive revenue growth and expand product portfolio and offerings.
Some key findings from the report:
-
- Among the type segments, the liver-on-a-chip segment is projected to account for significantly rapid revenue growth between 2021 and 2028 owing to capability of liver-on-a-chip to maintain metabolic activities that are almost alike in vitro environment. These liver chips are easy to use, affordable, and the best-suited alternative for animal models.
- Among the application segments, the drug discovery segment is expected to account for significantly large revenue share than other application segments owing to high investments in research and development of organoids and constantly growing need for novel drugs for rare liver diseases.
- Among the end use segments, the pharmaceutical and biotechnology companies segment is expected to account for high revenue growth rate over the forecast period as many leading companies are focusing on developing more effective drugs to cater to rising prevalence of liver dysfunctions.
- North America market is projected to account for largest revenue share in the global market over the forecast period due to presence of well-established life science companies, growing public awareness about organoids, and high prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD).
- The market in Europe is projected to account for substantial revenue growth attributable to factors such as high rate of liver disorders, highly developed healthcare and research centers, and rising investments in research for developing organoids.
Competitive Landscape:
The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, mergers and acquisitions, collaborations, and joint ventures to gain a robust footing in the market.
Top Companies Profiled in the Report:
Emulate Inc., Ascendance Bio, Organovo Holdings Inc., CN Bio Innovations, Cyfuse Biomedical, HìREL, InSphero, BioIVT, and Mimetas.
To know more about the report, visit @ https://www.reportsanddata.com/report-detail/human-liver-models-market
Human Liver Models Market Segmentation:
Based On Type: (Revenue, USD Billion, 2018 - 2028)
- Liver Organoids
- Liver-on-a-chip
- 2D Models
- Animals Models
- 3D Bioprinting
Based On Application: (Revenue, USD Billion, 2018 - 2028)
- Educational
- Drug Discovery
- Others
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of the Middle East & Africa)
Ask for Customized Research Report @ https://www.reportsanddata.com/request-customization-form/4015
This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.
Explore Latest Trending Research Reports By Reports and Data:
Sports Medicine Market , By Product (Body Reconstruction Products, Body Support and Recovery Products, Body Monitoring and Evaluation, Accessories), By Application, By End-Use, and By Region Forecast To 2028
Intracranial Pressure Monitoring Market Analysis, By Techniques (Invasive, Non-Invasive), By Application (Intracerebral Hemorrhage, Meningitis, Subarachnoid Hemorrhage), By End-Use (Hospitals, Clinics, Specialty Centers, Others) And Region, Forecasts To 2026
Ophthalmic Knives Market Analysis, By Design (Straight Knives, Crescent Knives), By Type (Reusable, Disposable), By Material (Stainless Steel, Diamond) By Application (Endothelial Keratoplasty), By End Use (Hospitals) And By Region Forecasts To 2027
Breast Cancer Therapy Market Size, Share, Trends & Analysis By Drugs (Chemotherapy, Hormone Therapy, Targeted Therapy, Immunotherapy), By Radiation Therapies (External Radiation, Intra-operative Radiation), By End Use (Hospitals) Forecasts To 2026
Pulmonary Arterial Hypertension Market Analysis, By Product (Prostacyclin and Prostacyclin Analogs, Calcium Channel Blockers), By Technology (Cuff-Less BP Monitoring Devices), By Application (Early-Stage Drug Candidates), By End Use (Hospitals) Forecasts To 2026
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problem provide our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs